CLASS II ONGOING Device recall · Reported 22 Mar 2023 · FDA Enforcement Report
BD Ultra-Fine Insulin Syringe-Insulin Syringes are designed recalled
Becton Dickinson is recalling BD Ultra-Fine Insulin Syringe-Insulin Syringes are designed for administering insulin in, distributed nationwide in the US. The recall was initiated on 1 Feb 2023 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1243-2023
- FDA event ID
- 91495
- Recalling firm
- Becton Dickinson, Franklin Lakes, NJ
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 1 Feb 2023
- FDA classified
- 10 Mar 2023
- Reported
- 22 Mar 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Device type
- Syringes & Needles
Timeline
| 1 Feb 2023 | Recall initiated by company | |
| 10 Mar 2023 | Classified by FDA | +37 days |
| 22 Mar 2023 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719
Where it was distributed
Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
Questions about this recall
Why was it recalled?
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
Which lots are affected?
GTIN: N/A Lot Number: 2031581, Exp. Date: 2031581
Where was it sold?
Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
7 other products · FDA event 91495This product is part of a recall event; the main page for the event is BD Ultra-Fine Insulin Syringe-Insulin Syringes are designed recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | BD Ultra-Fine Insulin Syringe-Insulin Syringes are designed recalled | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Insulin Syringes with the BD Micro-Fine IV Needle Single recalled | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Ultra-Fine Insulin Syringe recalled by Becton Dickinson & | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Ultra-Fine II Insulin Syringe-Insulin Syringes recalled | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Insulin Syringes with the BD Micro-Fine IV Needle recalled | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Ultra-Fine Insulin Syringe-Insulin Syringes are designed recalled | Becton Dickinson | Sterility | Nationwide | |
| CLASS II | BD Insulin Syringes with the BD Micro-Fine TM IV Needle recalled | Becton Dickinson | Sterility | Nationwide |
More recalls from Becton Dickinson
All 364| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | BD¿Spinal Tray with BD¿Whitacre Needle recalled by Becton Dickinson & | Becton Dickinson | Processing Deviation | Nationwide |
| Device | CLASS I | BD¿Spinal Tray with BD¿Whitacre Needle recalled by Becton Dickinson & | Becton Dickinson | Processing Deviation | Nationwide |
| Device | CLASS I | BD¿Spinal Tray with BD¿Quincke Needle recalled by Becton Dickinson & | Becton Dickinson | Processing Deviation | Nationwide |
| Device | CLASS I | BD¿Spinal Tray with BD¿Whitacre Needle recalled by Becton Dickinson & | Becton Dickinson | Processing Deviation | Nationwide |
| Device | CLASS I | BD¿Spinal Tray with BD¿Whitacre Needle, BD¿Quincke Needle recalled | Becton Dickinson | Processing Deviation | Nationwide |
Other Syringes & Needles recalls
All 1,060| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | BD Needle Kit for Powered Driver recalled by Bard Access Systems | Bard Access Systems | Other | 32 states |
| Device | CLASS II | Boston Scientific Enhance Transcarotid/Peripheral Access Kit recalled | Galt Medical | Other | Nationwide |
| Device | CLASS II | Geneva Brachytherapy Applicator recalled by Elekta | Elekta | Other | Nationwide |
| Device | CLASS II | Brachytherapy Applicator Advanced Gynecological Applicator recalled | Elekta | Other | Nationwide |
| Device | CLASS II | Medline 111 Gravity Set W/3 Needle Free Y-Sites recalled | BD Switzerland Sarl | Other | IL |